| European Case Law Identifier: | ECLI:EP:BA:2012:T020910.20121023 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 23 October 2012 | ||||||||
| Case number: | T 0209/10 | ||||||||
| Application number: | 04101615.5 | ||||||||
| IPC class: | A61K 31/4535 A61P 19/10 A61P 5/24 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Raloxifene in the treatment of postmenopausal osteoporosis | ||||||||
| Applicant name: | ELI LILLY AND COMPANY | ||||||||
| Opponent name: | Teva Pharmaceuticals Industries Ltd. TECNIMEDE SOCIEDADE TECNICO-MEDICINAL S.A. Hammer, Jens |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request: added matter (yes) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t100209eu1.html
Date retrieved: 17 May 2021